| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-06 | 2009-09-30 | 13F-HR | Ar Asset Managment Inc | Institution | 10,000 | No Change | 0 | 0 % | $266,000 | $266,000 | $0 | 0.00 % | $0 | | | | | | News Article | History of Ar Asset Managment Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Chwab Charles Investment Management Inc | Institution | 15,500 | Sold Some | -9,000 | -36.73 % | $412,300 | $412,300 | $0 | 0.00 % | $0 | | | | | | News Article | History of Chwab Charles Investment Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Credit Suisse First Boston | Institution | 18,000 | Sold Some | -48,477 | -72.92 % | $478,800 | $478,800 | $0 | 0.00 % | $0 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Hartford Investment Management Co | Institution | 150,442 | Added More | 31,500 | 26.48 % | $4,001,757 | $4,001,757 | $0 | 0.00 % | $0 | | | | | | News Article | History of Hartford Investment Management Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metlife Securities Inc | Institution | 4,673 | Added More | 3,673 | 367.30 % | $124,302 | $124,302 | $0 | 0.00 % | $0 | | | | | | News Article | History of Metlife Securities Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 55,512 | Added More | 4,288 | 8.37 % | $1,476,619 | $1,476,619 | $0 | 0.00 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pioneer Investment Management Inc | Institution | | Sold All | -50,500 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Pioneer Investment Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 100 | Sold Some | -639 | -86.46 % | $2,660 | $2,660 | $0 | 0.00 % | $0 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tcw Group Inc | Institution | 37,500 | Sold Some | -5,400 | -12.58 % | $997,500 | $997,500 | $0 | 0.00 % | $0 | | | | | | News Article | History of Tcw Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 131,124 | Added More | 8,798 | 7.19 % | $3,487,898 | $3,487,898 | $0 | 0.00 % | $0 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 361,610 | Added More | 28,292 | 8.48 % | $9,618,826 | $9,618,826 | $0 | 0.00 % | $0 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Trilogy Global Advisors Llc | Institution | | Sold All | -18,700 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Trilogy Global Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Unionbancal Corp | Institution | 1,200 | No Change | 0 | 0 % | $31,920 | $31,920 | $0 | 0.00 % | $0 | | | | | | News Article | History of Unionbancal Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | John Hancock Funds Ii-All Cap Growth Fund | Multi-Cap Growth | 25,330 | New Holding | 25,330 | 100 % | $673,778 | $673,778 | $0 | 0.00 % | $0 | | | | | | News Article | History of John Hancock Funds Ii-All Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | John Hancock Funds Ii-All Cap Value Fund | Multi-Cap Core | | Sold All | -42,200 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of John Hancock Funds Ii-All Cap Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | John Hancock Funds Ii-Value Fund | Multi-Cap Core | 30,000 | New Holding | 30,000 | 100 % | $798,000 | $798,000 | $0 | 0.00 % | $0 | | | | | | News Article | History of John Hancock Funds Ii-Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | Valic Co Ii-Small Cap Value Fund | Small-Cap Value | 10,300 | Added More | 2,500 | 32.05 % | $273,980 | $273,980 | $0 | 0.00 % | $0 | | | | | | News Article | History of Valic Co Ii-Small Cap Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Bank Of Hawaii | Institution | 9,800 | Sold Some | -5,700 | -36.77 % | $260,386 | $260,680 | $294 | 0.11 % | $-171 | | | | | | News Article | History of Bank Of Hawaii Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Fixed Income Securities Lp | Institution | 154 | New Holding | 154 | 100 % | $4,092 | $4,096 | $5 | 0.11 % | $5 | | | | | | News Article | History of Fixed Income Securities Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Nisa Investment Advisors L L C | Institution | 10,000 | Sold Some | -3,200 | -24.24 % | $265,700 | $266,000 | $300 | 0.11 % | $-96 | | | | | | News Article | History of Nisa Investment Advisors L L C Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associate | Institution | 36,038 | Added More | 1,424 | 4.11 % | $957,530 | $958,611 | $1,081 | 0.11 % | $43 | | | | | | News Article | History of Parametric Portfolio Associate Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Profund Advisors Llc | Institution | 10,476 | Added More | 978 | 10.29 % | $278,347 | $278,662 | $314 | 0.11 % | $29 | | | | | | News Article | History of Profund Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 17,584 | Sold Some | -6,634 | -27.39 % | $467,207 | $467,734 | $528 | 0.11 % | $-199 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Curian Capital Llc | Institution | 11,695 | New Holding | 11,695 | 100 % | $308,514 | $311,087 | $2,573 | 0.83 % | $2,573 | | | | | | News Article | History of Curian Capital Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Fort Washington Investment Advisors Inc | Institution | 180,135 | Added More | 14,160 | 8.53 % | $4,751,961 | $4,791,591 | $39,630 | 0.83 % | $3,115 | | | | | | News Article | History of Fort Washington Investment Advisors Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Gw Capital Management Incco | Institution | 47,900 | New Holding | 47,900 | 100 % | $1,263,602 | $1,274,140 | $10,538 | 0.83 % | $10,538 | | | | | | News Article | History of Gw Capital Management Incco Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Tradeworx Inc | Institution | 21,504 | New Holding | 21,504 | 100 % | $567,276 | $572,006 | $4,731 | 0.83 % | $4,731 | | | | | | News Article | History of Tradeworx Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Alliancebernstein Portfolios-Alliancebernstein Growth Fund | Multi-Cap Growth | 180,700 | New Holding | 180,700 | 100 % | $4,766,866 | $4,806,620 | $39,754 | 0.83 % | $39,754 | | | | | | News Article | History of Alliancebernstein Portfolios-Alliancebernstein Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Ixis Asset Management Advisors L P | Institution | 12,351 | Sold Some | -701 | -5.37 % | $336,565 | $328,537 | $-8,028 | -2.38 % | $456 | | | | | | News Article | History of Ixis Asset Management Advisors L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | M And T Bank Corp | Institution | | Sold All | -20,225 | -100 % | | | | -2.38 % | $13,146 | | | | | | News Article | History of M And T Bank Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Parta Asset Management Llc | Institution | 93,582 | New Holding | 93,582 | 100 % | $2,550,110 | $2,489,281 | $-60,828 | -2.38 % | $-60,828 | | | | | | News Article | History of Parta Asset Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 171,370 | Added More | 159,780 | 1378.60 % | $4,669,833 | $4,558,442 | $-111,391 | -2.38 % | $-103,857 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Emerald Advisers Inc | Institution | 84,296 | New Holding | 84,296 | 100 % | $2,229,629 | $2,242,274 | $12,644 | 0.56 % | $12,644 | | | | | | News Article | History of Emerald Advisers Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Emerald Mutual Fund Advisers Trust | Institution | 34,540 | New Holding | 34,540 | 100 % | $913,583 | $918,764 | $5,181 | 0.56 % | $5,181 | | | | | | News Article | History of Emerald Mutual Fund Advisers Trust Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios-Pharmaceuticals Portfolio | Health/Biotech | 1,500 | Sold Some | -9,000 | -85.71 % | $39,675 | $39,900 | $225 | 0.56 % | $-1,350 | | | | | | News Article | History of Fidelity Select Portfolios-Pharmaceuticals Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios-Technology Portfolio | Science & Tech | 277,552 | Sold Some | -122,000 | -30.53 % | $7,341,250 | $7,382,883 | $41,633 | 0.56 % | $-18,300 | | | | | | News Article | History of Fidelity Select Portfolios-Technology Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | 64,468 | Added More | 49,962 | 344.42 % | $1,714,849 | $1,714,849 | $0 | 0.00 % | $0 | | | | | | News Article | History of Oxford Asset Management Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Tonebridge Capital Management Inc | Institution | 19,655 | Sold Some | -4,970 | -20.18 % | $522,823 | $522,823 | $0 | 0.00 % | $0 | | | | | | News Article | History of Tonebridge Capital Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I-Balanced Fund | Mixed-Asset Target Allocation Moderate | 20,978 | Added More | 5,889 | 39.02 % | $558,015 | $558,015 | $0 | 0.00 % | $0 | | | | | | News Article | History of Fidelity Advisor Series I-Balanced Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I-Growth Opportunities Fund | Large-Cap Core | 43,700 | New Holding | 43,700 | 100 % | $1,162,420 | $1,162,420 | $0 | 0.00 % | $0 | | | | | | News Article | History of Fidelity Advisor Series I-Growth Opportunities Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSRS | Fidelity Commonwealth Trust Ii-Fidelity Small Cap Enhanced Index Fund | Small-Cap Core | 300 | Sold Some | -780 | -72.22 % | $7,980 | $7,980 | $0 | 0.00 % | $0 | | | | | | News Article | History of Fidelity Commonwealth Trust Ii-Fidelity Small Cap Enhanced Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 2,226 | No Compare | | | $59,212 | $59,212 | $0 | 0.00 % | | | | | | | News Article | History of Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust-Fidelity Aggressive Growth Fund | Multi-Cap Growth | | Sold All | -30,000 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust-Fidelity Aggressive Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust-Fidelity Growth Company Fund | Multi-Cap Growth | 1,000,000 | Added More | 451,988 | 82.47 % | $26,600,000 | $26,600,000 | $0 | 0.00 % | $0 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust-Fidelity Growth Company Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Lord Abbett Research Fund Inc-Americas Value Fund | Multi-Cap Value | 949,118 | New Holding | 949,118 | 100 % | $25,246,539 | $25,246,539 | $0 | 0.00 % | $0 | | | | | | News Article | History of Lord Abbett Research Fund Inc-Americas Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Lord Abbett Research Fund Inc-Growth Opportunities Fund | Mid-Cap Growth | 43,857 | New Holding | 43,857 | 100 % | $1,166,596 | $1,166,596 | $0 | 0.00 % | $0 | | | | | | News Article | History of Lord Abbett Research Fund Inc-Growth Opportunities Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund-Vanguard Health Care Index Fund | Health/Biotech | 27,829 | New Holding | 27,829 | 100 % | $740,251 | $740,251 | $0 | 0.00 % | $0 | | | | | | News Article | History of Vanguard World Fund-Vanguard Health Care Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 77,565 | Sold Some | -5,600 | -6.73 % | $2,008,158 | $2,063,229 | $55,071 | 2.74 % | $-3,976 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Lyz Capital Advisors Llc | Institution | 28,952 | Added More | 7,000 | 31.88 % | $749,567 | $770,123 | $20,556 | 2.74 % | $4,970 | | | | | | News Article | History of Lyz Capital Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Forum Funds-Shaker Fund | Specialty & Misc | | Sold All | -5,900 | -100 % | | | | 2.74 % | $-4,189 | | | | | | News Article | History of Forum Funds-Shaker Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Riversource Equity Series Inc-Riversource Mid Cap Growth Fund | Mid-Cap Growth | 87,675 | New Holding | 87,675 | 100 % | $2,269,906 | $2,332,155 | $62,249 | 2.74 % | $62,249 | | | | | | News Article | History of Riversource Equity Series Inc-Riversource Mid Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust-Cornerstone Strategy Fund | Specialty & Misc | | Sold All | -3,300 | -100 % | | | | 2.74 % | $-2,343 | | | | | | News Article | History of Usaa Mutual Funds Trust-Cornerstone Strategy Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I-Health Sciences Fund | Health/Biotech | 28,800 | No Change | 0 | 0 % | $745,632 | $766,080 | $20,448 | 2.74 % | $0 | | | | | | News Article | History of Valic Co I-Health Sciences Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I-Small Cap Fund | Small-Cap Core | 3,600 | New Holding | 3,600 | 100 % | $93,204 | $95,760 | $2,556 | 2.74 % | $2,556 | | | | | | News Article | History of Valic Co I-Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I-Small Cap Index Fund | Small-Cap Core | 49,970 | New Holding | 49,970 | 100 % | $1,293,723 | $1,329,202 | $35,479 | 2.74 % | $35,479 | | | | | | News Article | History of Valic Co I-Small Cap Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Brazos Mutual Funds-Brazos Small Cap Portfolio | Small-Cap Growth | 5,100 | New Holding | 5,100 | 100 % | $128,163 | $135,660 | $7,497 | 5.84 % | $7,497 | | | | | | News Article | History of Brazos Mutual Funds-Brazos Small Cap Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Dupont Capital Management | Institution | 67,114 | New Holding | 67,114 | 100 % | $1,712,078 | $1,785,232 | $73,154 | 4.27 % | $73,154 | | | | | | News Article | History of Dupont Capital Management Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Forward Management Llc | Institution | 250 | No Change | 0 | 0 % | $6,378 | $6,650 | $273 | 4.27 % | $0 | | | | | | News Article | History of Forward Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Claymore Exchange Traded Fund Trust-Claymoremorningstar Services Super Sector Index Etf | Specialty & Misc | 30 | No Change | 0 | 0 % | $755 | $798 | $44 | 5.76 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust-Claymoremorningstar Services Super Sector Index Etf Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-CSR | Eaton Vance Growth Trust-Eaton Vance Worldwide Health Sciences Fund | Health/Biotech | | Sold All | -1,351,200 | -100 % | | | | 5.76 % | $-1,959,240 | | | | | | News Article | History of Eaton Vance Growth Trust-Eaton Vance Worldwide Health Sciences Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Legg Mason Partners Equity Trust-Legg Mason Partners Mid Cap Core Fund | Mid-Cap Core | | Sold All | -440,000 | -100 % | | | | 5.76 % | $-638,000 | | | | | | News Article | History of Legg Mason Partners Equity Trust-Legg Mason Partners Mid Cap Core Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc-Tdax Independence 2010 Exchange-Traded Fund | Mixed-Asset Target 2010 Funds | | Sold All | -85 | -100 % | | | | 5.76 % | $-123 | | | | | | News Article | History of Tdax Funds Inc-Tdax Independence 2010 Exchange-Traded Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc-Tdax Independence 2020 Exchange-Traded Fund | Mixed-Asset Target 2020 Funds | | Sold All | -553 | -100 % | | | | 5.76 % | $-802 | | | | | | News Article | History of Tdax Funds Inc-Tdax Independence 2020 Exchange-Traded Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc-Tdax Independence 2030 Exchange-Traded Fund | Mixed-Asset Target 2030 Funds | | Sold All | -648 | -100 % | | | | 5.76 % | $-940 | | | | | | News Article | History of Tdax Funds Inc-Tdax Independence 2030 Exchange-Traded Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc-Tdax Independence 2040 Exchange-Traded Fund | Mixed-Asset Target 2030+ Funds | | Sold All | -768 | -100 % | | | | 5.76 % | $-1,114 | | | | | | News Article | History of Tdax Funds Inc-Tdax Independence 2040 Exchange-Traded Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc-Tdax Independence In-Target Exchange-Traded Fund | Specialty & Misc | | Sold All | -75 | -100 % | | | | 5.76 % | $-109 | | | | | | News Article | History of Tdax Funds Inc-Tdax Independence In-Target Exchange-Traded Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-CSR | Worldwide Health Sciences Portfolio-Worldwide Health Science | Health/Biotech | | Sold All | -1,351,200 | -100 % | | | | 5.76 % | $-1,959,240 | | | | | | News Article | History of Worldwide Health Sciences Portfolio-Worldwide Health Science Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | 42,800 | Added More | 24,326 | 131.67 % | $1,099,532 | $1,138,480 | $38,948 | 3.54 % | $22,137 | | | | | | News Article | History of Blackrock Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | Lord Abbett Developing Growth Fund Inc New-Lord Abbett Developing Growth Fund Inc New | Small-Cap Growth | 168,800 | Sold Some | -370 | -0.21 % | $4,540,720 | $4,490,080 | $-50,640 | -1.11 % | $111 | | | | | | News Article | History of Lord Abbett Developing Growth Fund Inc New-Lord Abbett Developing Growth Fund Inc New Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | World Funds Trust-Commonwealth Small Cap Fund | No Data | 250 | New Holding | 250 | 100 % | $6,725 | $6,650 | $-75 | -1.11 % | $-75 | | | | | | News Article | History of World Funds Trust-Commonwealth Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii-Fidelity Advisor Biotechnology Fund | Health/Biotech | 29,896 | Added More | 11,448 | 62.05 % | $835,593 | $795,234 | $-40,360 | -4.83 % | $-15,455 | | | | | | News Article | History of Fidelity Advisor Series Vii-Fidelity Advisor Biotechnology Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii-Fidelity Advisor Health Care Fund | Health/Biotech | | Sold All | -22,103 | -100 % | | | | -4.83 % | $29,839 | | | | | | News Article | History of Fidelity Advisor Series Vii-Fidelity Advisor Health Care Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSRS | Fidelity Devonshire Trust-Fidelity Series All-Sector Equity Fund | No Data | 225,635 | Added More | 125,565 | 125.47 % | $6,306,498 | $6,001,891 | $-304,607 | -4.83 % | $-169,513 | | | | | | News Article | History of Fidelity Devonshire Trust-Fidelity Series All-Sector Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds-Bull Profund | Large-Cap Core | 2,120 | Added More | 1,050 | 98.13 % | $59,254 | $56,392 | $-2,862 | -4.83 % | $-1,418 | | | | | | News Article | History of Profunds-Bull Profund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds-Health Care Ultrasector Profund | Health/Biotech | 219 | Added More | 117 | 114.70 % | $6,121 | $5,825 | $-296 | -4.83 % | $-158 | | | | | | News Article | History of Profunds-Health Care Ultrasector Profund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds-Technology Ultrasector Profund | Science & Tech | 2,856 | New Holding | 2,856 | 100 % | $79,825 | $75,970 | $-3,856 | -4.83 % | $-3,856 | | | | | | News Article | History of Profunds-Technology Ultrasector Profund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Alliancebernstein Cap Fund Inc-Alliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 85,000 | Added More | 14,700 | 20.91 % | $2,455,650 | $2,261,000 | $-194,650 | -7.92 % | $-33,663 | | | | | | News Article | History of Alliancebernstein Cap Fund Inc-Alliancebernstein Small Cap Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Alliancebernstein Mid Cap Growth Fund Inc-Alliancebernstein Mid Cap Growth Fund Inc | Mid-Cap Growth | 118,900 | Added More | 20,000 | 20.22 % | $3,435,021 | $3,162,740 | $-272,281 | -7.92 % | $-45,800 | | | | | | News Article | History of Alliancebernstein Mid Cap Growth Fund Inc-Alliancebernstein Mid Cap Growth Fund Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Pacific Capital Funds-Small Cap Fund | Small-Cap Value | 13,600 | Sold Some | -3,600 | -20.93 % | $392,904 | $361,760 | $-31,144 | -7.92 % | $8,244 | | | | | | News Article | History of Pacific Capital Funds-Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust-Value Fund | Multi-Cap Value | | Sold All | -13,000 | -100 % | | | | -7.92 % | $29,770 | | | | | | News Article | History of Usaa Mutual Funds Trust-Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc-New Opportunities Fund | Small-Cap Growth | 18,047 | Sold Some | -1,838 | -9.24 % | $578,587 | $480,050 | $-98,537 | -17.03 % | $10,035 | | | | | | News Article | History of American Century Mutual Funds Inc-New Opportunities Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc-New Opportunities Ii | Small-Cap Growth | 61,447 | Sold Some | -12,321 | -16.70 % | $1,969,991 | $1,634,490 | $-335,501 | -17.03 % | $67,273 | | | | | | News Article | History of American Century Mutual Funds Inc-New Opportunities Ii Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc-International Core Equity Portfolio | International Small-Mid-Cap Value | 45,700 | New Holding | 45,700 | 100 % | $1,465,142 | $1,215,620 | $-249,522 | -17.03 % | $-249,522 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc-International Core Equity Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc-International Vector Equity Portfolio | No Data | 4,600 | New Holding | 4,600 | 100 % | $147,476 | $122,360 | $-25,116 | -17.03 % | $-25,116 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc-International Vector Equity Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc-Us Sustainability Core 1 Portfolio | No Data | 900 | New Holding | 900 | 100 % | $28,854 | $23,940 | $-4,914 | -17.03 % | $-4,914 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc-Us Sustainability Core 1 Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Evergreen Equity Trust De-Evergreen Health Care Fund | Health/Biotech | 79,557 | Sold Some | -10,475 | -11.63 % | $2,550,597 | $2,116,216 | $-434,381 | -17.03 % | $57,194 | | | | | | News Article | History of Evergreen Equity Trust De-Evergreen Health Care Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | First American Investment Funds Inc-Small Cap Growth Opportunities Fund | Small-Cap Growth | 32,233 | New Holding | 32,233 | 100 % | $1,033,390 | $857,398 | $-175,992 | -17.03 % | $-175,992 | | | | | | News Article | History of First American Investment Funds Inc-Small Cap Growth Opportunities Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | First American Investment Funds Inc-Small Cap Select Fund | Small-Cap Core | 94,367 | New Holding | 94,367 | 100 % | $3,025,406 | $2,510,162 | $-515,244 | -17.03 % | $-515,244 | | | | | | News Article | History of First American Investment Funds Inc-Small Cap Select Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Heritage Series Trust-Diversified Growth Fund | Multi-Cap Growth | 87,265 | No Change | 0 | 0 % | $2,797,716 | $2,321,249 | $-476,467 | -17.03 % | $0 | | | | | | News Article | History of Heritage Series Trust-Diversified Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust-Ishares Morningstar Small Growth Index Fund | Small-Cap Growth | 18,824 | Added More | 3,597 | 23.62 % | $603,497 | $500,718 | $-102,779 | -17.03 % | $-19,640 | | | | | | News Article | History of Ishares Trust-Ishares Morningstar Small Growth Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund-Janus Fund | Large-Cap Growth | 271,613 | New Holding | 271,613 | 100 % | $8,707,913 | $7,224,906 | $-1,483,007 | -17.03 % | $-1,483,007 | | | | | | News Article | History of Janus Investment Fund-Janus Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust-Jackson Perspective Index 5 Fund | Specialty & Misc | 587 | No Change | 0 | 0 % | $18,819 | $15,614 | $-3,205 | -17.03 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust-Jackson Perspective Index 5 Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Mainstay Funds-Mainstay Small Cap Growth Fund | Small-Cap Growth | 20,700 | Added More | 800 | 4.02 % | $663,642 | $550,620 | $-113,022 | -17.03 % | $-4,368 | | | | | | News Article | History of Mainstay Funds-Mainstay Small Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard Explorer Fund-Vanguard Explorer Fund | Small-Cap Growth | 204,493 | Added More | 4,843 | 2.42 % | $6,556,046 | $5,439,514 | $-1,116,532 | -17.03 % | $-26,443 | | | | | | News Article | History of Vanguard Explorer Fund-Vanguard Explorer Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-CSRS | Vanguard Specialized Funds-Vanguard Health Care Fund | Health/Biotech | 807,200 | New Holding | 807,200 | 100 % | $25,878,832 | $21,471,520 | $-4,407,312 | -17.03 % | $-4,407,312 | | | | | | News Article | History of Vanguard Specialized Funds-Vanguard Health Care Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Harbor Funds-Harbor Mid Cap Growth Fund | Mid-Cap Growth | | Sold All | -44,274 | -100 % | | | | -18.15 % | $261,217 | | | | | | News Article | History of Harbor Funds-Harbor Mid Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Harbor Funds-Harbor Small Company Growth Fund | Small-Cap Growth | 13,458 | New Holding | 13,458 | 100 % | $437,385 | $357,983 | $-79,402 | -18.15 % | $-79,402 | | | | | | News Article | History of Harbor Funds-Harbor Small Company Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Legg Mason Partners Variable Equity Trust-Legg Mason Partners Variable Mid Cap Core Portfolio | Mid-Cap Core | 35,000 | Added More | 13,000 | 59.09 % | $1,137,500 | $931,000 | $-206,500 | -18.15 % | $-76,700 | | | | | | News Article | History of Legg Mason Partners Variable Equity Trust-Legg Mason Partners Variable Mid Cap Core Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Lord Abbett Securities Trust-Lord Abbett All Value Fund | Multi-Cap Value | | Sold All | -1,042,900 | -100 % | | | | -18.15 % | $6,153,110 | | | | | | News Article | History of Lord Abbett Securities Trust-Lord Abbett All Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds-Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | | Sold All | -900 | -100 % | | | | -18.15 % | $5,310 | | | | | | News Article | History of Massmutual Premier Funds-Massmutual Premier Main Street Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds-Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | | Sold All | -1,700 | -100 % | | | | -18.15 % | $10,030 | | | | | | News Article | History of Massmutual Premier Funds-Massmutual Premier Small Company Opportunities Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust-Powershares Dynamic Market Portfolio | Specialty & Misc | | Sold All | -116,911 | -100 % | | | | -18.15 % | $689,775 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust-Powershares Dynamic Market Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange-Traded Fund Trust Ii-Powershares Global Biotech Portfolio | No Data | 1,285 | Added More | 88 | 7.35 % | $41,763 | $34,181 | $-7,582 | -18.15 % | $-519 | | | | | | News Article | History of Powershares Exchange-Traded Fund Trust Ii-Powershares Global Biotech Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust-Direxion Daily Small Cap Bull 3x Shares | No Data | | Sold All | -17,271 | -100 % | | | | -16.58 % | $91,364 | | | | | | News Article | History of Direxion Shares Etf Trust-Direxion Daily Small Cap Bull 3x Shares Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds-Mtb Multi Cap Growth Fund | Multi-Cap Core | 350 | Sold Some | -75 | -17.64 % | $11,162 | $9,310 | $-1,852 | -16.58 % | $397 | | | | | | News Article | History of Mtb Group Of Funds-Mtb Multi Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds-Mtb Small Cap Growth Fund | Small-Cap Growth | 19,000 | Added More | 7,500 | 65.21 % | $605,910 | $505,400 | $-100,510 | -16.58 % | $-39,675 | | | | | | News Article | History of Mtb Group Of Funds-Mtb Small Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Tonebridge Funds Trust-Stonebridge Growth Fund | Multi-Cap Growth | 10,750 | New Holding | 10,750 | 100 % | $342,818 | $285,950 | $-56,868 | -16.58 % | $-56,868 | | | | | | News Article | History of Tonebridge Funds Trust-Stonebridge Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Forum Funds-Shaker Fund | Specialty & Misc | 5,900 | New Holding | 5,900 | 100 % | $186,145 | $156,940 | $-29,205 | -15.68 % | $-29,205 | | | | | | News Article | History of Forum Funds-Shaker Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfus Premier Opportunity Funds-Health Care Fund | Health/Biotech | 4,850 | Sold Some | -1,950 | -28.67 % | $164,706 | $129,010 | $-35,696 | -21.67 % | $14,352 | | | | | | News Article | History of Dreyfus Premier Opportunity Funds-Health Care Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust-Rydex Inverse Russell 2000 Etf | Specialty & Misc | 1,220 | New Holding | 1,220 | 100 % | $42,139 | $32,452 | $-9,687 | -22.98 % | $-9,687 | | | | | | News Article | History of Rydex Etf Trust-Rydex Inverse Russell 2000 Etf Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-15 | 2009-06-30 | N-CSRS/A | Wilshire Mutual Funds Inc-Wilshire Small Company Growth Portfolio | Small-Cap Growth | | Sold All | -550 | -100 % | | | | -24.53 % | $4,758 | | | | | | News Article | History of Wilshire Mutual Funds Inc-Wilshire Small Company Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-09 | 2009-06-30 | N-CSRS | Value Line Centurion Fund Inc-Value Line Centurion Fund Inc | Multi-Cap Value | | Sold All | -35,000 | -100 % | | | | -21.27 % | $251,650 | | | | | | News Article | History of Value Line Centurion Fund Inc-Value Line Centurion Fund Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-09 | 2009-06-30 | N-CSRS | Value Line Fund Inc-Value Line Fund Inc | Multi-Cap Growth | | Sold All | -26,000 | -100 % | | | | -21.27 % | $186,940 | | | | | | News Article | History of Value Line Fund Inc-Value Line Fund Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Jpmorgan Trust Ii-Jpmorgan Technology Fund | Science & Tech | 5 | New Holding | 5 | 100 % | $162 | $133 | $-29 | -17.97 % | $-29 | | | | | | News Article | History of Jpmorgan Trust Ii-Jpmorgan Technology Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds-Banking Fund | Financial Services | 38,716 | Added More | 36,920 | 2055.67 % | $1,255,560 | $1,029,846 | $-225,714 | -17.97 % | $-215,244 | | | | | | News Article | History of Rydex Series Funds-Banking Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust-Biotechnology Fund | Health/Biotech | 24,489 | Added More | 6,966 | 39.75 % | $794,178 | $651,407 | $-142,771 | -17.97 % | $-40,612 | | | | | | News Article | History of Rydex Variable Trust-Biotechnology Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Timothy Plan-Timothy Aggressive Growth Fund | Multi-Cap Growth | | Sold All | -2,125 | -100 % | | | | -17.97 % | $12,389 | | | | | | News Article | History of Timothy Plan-Timothy Aggressive Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-08-17 | N-CSR | John Hancock Trust-Growth Trust | Multi-Cap Growth | 57,900 | New Holding | 57,900 | 100 % | $1,829,061 | $1,540,140 | $-288,921 | -15.79 % | $-288,921 | | | | | | News Article | History of John Hancock Trust-Growth Trust Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | American Funds Insurance Series-Growth Fund | Multi-Cap Growth | 1,000,000 | No Change | 0 | 0 % | $31,590,000 | $26,600,000 | $-4,990,000 | -15.79 % | $0 | | | | | | News Article | History of American Funds Insurance Series-Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust-Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 168,460 | Added More | 82,175 | 95.23 % | $5,321,651 | $4,481,036 | $-840,615 | -15.79 % | $-410,053 | | | | | | News Article | History of Axa Premier Vip Trust-Multimanager Small Cap Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust-Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 398,200 | Added More | 241,700 | 154.44 % | $12,579,138 | $10,592,120 | $-1,987,018 | -15.79 % | $-1,206,083 | | | | | | News Article | History of Eq Advisors Trust-Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust-Eqalliancebernstein Value Portfolio | Multi-Cap Value | 10,100 | New Holding | 10,100 | 100 % | $319,059 | $268,660 | $-50,399 | -15.79 % | $-50,399 | | | | | | News Article | History of Eq Advisors Trust-Eqalliancebernstein Value Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust-Eqbond Index Portfolio | Specialty & Misc | 185,300 | Added More | 109,800 | 145.43 % | $5,853,627 | $4,928,980 | $-924,647 | -15.79 % | $-547,902 | | | | | | News Article | History of Eq Advisors Trust-Eqbond Index Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Forward Funds-Forward Legato Fund | Small-Cap Core | | Sold All | -7,009 | -100 % | | | | -15.79 % | $34,975 | | | | | | News Article | History of Forward Funds-Forward Legato Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Frontegra Funds Inc-Frontegra Ironbridge Smid Fund | Mid-Cap Core | | Sold All | -56,051 | -100 % | | | | -15.79 % | $279,694 | | | | | | News Article | History of Frontegra Funds Inc-Frontegra Ironbridge Smid Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I-Jpmorgan Japan Fund | Japanese | | Sold All | -5 | -100 % | | | | -15.79 % | $25 | | | | | | News Article | History of Jpmorgan Trust I-Jpmorgan Japan Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I-Jpmorgan Prime Money Market Fund | Specialty & Misc | 15 | New Holding | 15 | 100 % | $474 | $399 | $-75 | -15.79 % | $-75 | | | | | | News Article | History of Jpmorgan Trust I-Jpmorgan Prime Money Market Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I-Jpmorgan Small Cap Core Fund | Small-Cap Core | 19 | No Change | 0 | 0 % | $600 | $505 | $-95 | -15.79 % | $0 | | | | | | News Article | History of Jpmorgan Trust I-Jpmorgan Small Cap Core Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii-Jpmorgan Core Bond Fund | Multi-Cap Core | 19 | New Holding | 19 | 100 % | $600 | $505 | $-95 | -15.79 % | $-95 | | | | | | News Article | History of Jpmorgan Trust Ii-Jpmorgan Core Bond Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii-Jpmorgan Small Cap Value Fund | Small-Cap Value | 10 | Sold Some | -1 | -9.09 % | $316 | $266 | $-50 | -15.79 % | $5 | | | | | | News Article | History of Jpmorgan Trust Ii-Jpmorgan Small Cap Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds-Massmutual Select Mid Cap Growth Equity Fund | Mid-Cap Growth | | Sold All | -3,400 | -100 % | | | | -15.79 % | $16,966 | | | | | | News Article | History of Massmutual Select Funds-Massmutual Select Mid Cap Growth Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds-Massmutual Select Small Cap Growth Equity Fund | Small-Cap Growth | 20,150 | No Change | 0 | 0 % | $636,539 | $535,990 | $-100,549 | -15.79 % | $0 | | | | | | News Article | History of Massmutual Select Funds-Massmutual Select Small Cap Growth Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds-Massmutual Select Small Company Growth Fund | Small-Cap Growth | 15,095 | Added More | 4,870 | 47.62 % | $476,851 | $401,527 | $-75,324 | -15.79 % | $-24,301 | | | | | | News Article | History of Massmutual Select Funds-Massmutual Select Small Company Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds-Bull Profund | Large-Cap Core | 1,070 | Sold Some | -1,750 | -62.05 % | $33,801 | $28,462 | $-5,339 | -15.79 % | $8,733 | | | | | | News Article | History of Profunds-Bull Profund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds-Profund Vp Biotechnology | Health/Biotech | 3,402 | New Holding | 3,402 | 100 % | $107,469 | $90,493 | $-16,976 | -15.79 % | $-16,976 | | | | | | News Article | History of Profunds-Profund Vp Biotechnology Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds-Profund Vp Health Care | Health/Biotech | 1,512 | New Holding | 1,512 | 100 % | $47,764 | $40,219 | $-7,545 | -15.79 % | $-7,545 | | | | | | News Article | History of Profunds-Profund Vp Health Care Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Un Capital Advisers Trust-Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 1,600 | New Holding | 1,600 | 100 % | $50,544 | $42,560 | $-7,984 | -15.79 % | $-7,984 | | | | | | News Article | History of Un Capital Advisers Trust-Sc Oppenheimer Main Street Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds-Vanguard Institutional Index Fund | Specialty & Misc | 51,205 | New Holding | 51,205 | 100 % | $1,617,566 | $1,362,053 | $-255,513 | -15.79 % | $-255,513 | | | | | | News Article | History of Vanguard Institutional Index Funds-Vanguard Institutional Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds-Small Company Growth Portfolio | Small-Cap Growth | 10,700 | New Holding | 10,700 | 100 % | $338,013 | $284,620 | $-53,393 | -15.79 % | $-53,393 | | | | | | News Article | History of Vanguard Variable Insurance Funds-Small Company Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Advisors Series Trust-Capital Advisors Growth Fund | Multi-Cap Growth | | Sold All | -1,700 | -100 % | | | | -13.74 % | $7,208 | | | | | | News Article | History of Advisors Series Trust-Capital Advisors Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc-Jnlmcm Healthcare Sector Fund | Health/Biotech | 6 | No Change | 0 | 0 % | $185 | $160 | $-25 | -13.74 % | $0 | | | | | | News Article | History of Jnl Variable Fund Llc-Jnlmcm Healthcare Sector Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mainstay Vp Series Fund Inc-Vp Developing Growth Portfolio | Multi-Cap Growth | | Sold All | -12,500 | -100 % | | | | -13.74 % | $53,000 | | | | | | News Article | History of Mainstay Vp Series Fund Inc-Vp Developing Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mainstay Vp Series Fund Inc-Vp Small Cap Growth Portfolio | Small-Cap Growth | | Sold All | -21,600 | -100 % | | | | -13.74 % | $91,584 | | | | | | News Article | History of Mainstay Vp Series Fund Inc-Vp Small Cap Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii-Mml Small Cap Equity Fund | Small-Cap Core | 1,200 | New Holding | 1,200 | 100 % | $37,008 | $31,920 | $-5,088 | -13.74 % | $-5,088 | | | | | | News Article | History of Mml Series Investment Fund Ii-Mml Small Cap Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund-Mml Small Cap Growth Equity Fund | Small-Cap Growth | 7,080 | Sold Some | -300 | -4.06 % | $218,347 | $188,328 | $-30,019 | -13.74 % | $1,272 | | | | | | News Article | History of Mml Series Investment Fund-Mml Small Cap Growth Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | New Covenant Funds-New Covenant Growth Fund | No Data | | Sold All | -1,750 | -100 % | | | | -13.74 % | $7,420 | | | | | | News Article | History of New Covenant Funds-New Covenant Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ohio National Fund Inc-Bryton Growth Portfolio | Multi-Cap Growth | | Sold All | -10,000 | -100 % | | | | -13.74 % | $42,400 | | | | | | News Article | History of Ohio National Fund Inc-Bryton Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ohio National Fund Inc-Capital Growth Portfolio | Multi-Cap Growth | | Sold All | -6,610 | -100 % | | | | -13.74 % | $28,026 | | | | | | News Article | History of Ohio National Fund Inc-Capital Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund-Pd Small-Cap Growth Index Portfolio | No Data | 1,966 | No Compare | | | $60,631 | $52,296 | $-8,336 | -13.74 % | | | | | | | News Article | History of Pacific Select Fund-Pd Small-Cap Growth Index Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund-Small-Cap Index Portfolio | No Data | 60,324 | Added More | 30,162 | 100.00 % | $1,860,392 | $1,604,618 | $-255,774 | -13.74 % | $-127,887 | | | | | | News Article | History of Pacific Select Fund-Small-Cap Index Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Treettracks Series Trust-Spdr Dividend Etf | Specialty & Misc | | Sold All | -679,104 | -100 % | | | | -13.74 % | $2,879,401 | | | | | | News Article | History of Treettracks Series Trust-Spdr Dividend Etf Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds-Biotechnology Fund | Health/Biotech | 68,515 | Added More | 13,500 | 24.53 % | $2,160,278 | $1,822,499 | $-337,779 | -15.63 % | $-66,555 | | | | | | News Article | History of Rydex Series Funds-Biotechnology Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Fidelity Central Investment Portfolios Llc-Fidelity Health Care | Health/Biotech | | Sold All | -35,852 | -100 % | | | | -17.05 % | $196,110 | | | | | | News Article | History of Fidelity Central Investment Portfolios Llc-Fidelity Health Care Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Mutual Of America Investment Corp-Bond Fund | Specialty & Misc | 32,519 | Added More | 279 | 0.86 % | $1,042,884 | $865,005 | $-177,879 | -17.05 % | $-1,526 | | | | | | News Article | History of Mutual Of America Investment Corp-Bond Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund-Stock Index Fund | Specialty & Misc | 687 | Added More | 87 | 14.50 % | $22,032 | $18,274 | $-3,758 | -17.05 % | $-476 | | | | | | News Article | History of Tiaa Cref Life Fund-Stock Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust-Value Fund | Multi-Cap Value | 13,000 | New Holding | 13,000 | 100 % | $416,910 | $345,800 | $-71,110 | -17.05 % | $-71,110 | | | | | | News Article | History of Usaa Mutual Funds Trust-Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wisdomtree Trust-Wisdomtree Midcap Earnings Fund | Mid-Cap Core | 127 | No Change | 0 | 0 % | $4,073 | $3,378 | $-695 | -17.05 % | $0 | | | | | | News Article | History of Wisdomtree Trust-Wisdomtree Midcap Earnings Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Allianz Funds-Occ Value | Large-Cap Value | 54,910 | Added More | 3,155 | 6.09 % | $1,732,960 | $1,460,606 | $-272,354 | -15.71 % | $-15,649 | | | | | | News Article | History of Allianz Funds-Occ Value Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Calvert Fund-Calvert New Vision Small Cap Fund | Small-Cap Core | 24,400 | New Holding | 24,400 | 100 % | $770,064 | $649,040 | $-121,024 | -15.71 % | $-121,024 | | | | | | News Article | History of Calvert Fund-Calvert New Vision Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Calvert Social Index Series Inc-Calvert Social Index Fund | Multi-Cap Core | 899 | No Change | 0 | 0 % | $28,372 | $23,913 | $-4,459 | -15.71 % | $0 | | | | | | News Article | History of Calvert Social Index Series Inc-Calvert Social Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Columbia Funds Variable Insurance Trust-Columbia Asset Allocation Fund Variable Serie | Specialty & Misc | 863 | Sold Some | -40 | -4.42 % | $27,236 | $22,956 | $-4,280 | -15.71 % | $198 | | | | | | News Article | History of Columbia Funds Variable Insurance Trust-Columbia Asset Allocation Fund Variable Serie Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Columbia Funds Variable Insurance Trust-Columbia Small Company Growth Fund Variable Serie | Small-Cap Growth | 14,859 | Sold Some | -1,880 | -11.23 % | $468,950 | $395,249 | $-73,701 | -15.71 % | $9,325 | | | | | | News Article | History of Columbia Funds Variable Insurance Trust-Columbia Small Company Growth Fund Variable Serie Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Easons Series Trust-Stock Portfolio | Multi-Cap Core | 764 | New Holding | 764 | 100 % | $24,112 | $20,322 | $-3,789 | -15.71 % | $-3,789 | | | | | | News Article | History of Easons Series Trust-Stock Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 679,976 | Sold Some | -41,334 | -5.73 % | $21,460,043 | $18,087,362 | $-3,372,681 | -15.71 % | $205,017 | | | | | | News Article | History of Ishares Trust-Ishares Nasdaq Biotechnology Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 402,949 | Added More | 24,804 | 6.55 % | $12,717,070 | $10,718,443 | $-1,998,627 | -15.71 % | $-123,028 | | | | | | News Article | History of Ishares Trust-Ishares Russell 2000 Growth Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 2000 Index Fund | Specialty & Misc | 686,255 | Sold Some | -1,732 | -0.25 % | $21,658,208 | $18,254,383 | $-3,403,825 | -15.71 % | $8,591 | | | | | | News Article | History of Ishares Trust-Ishares Russell 2000 Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 3,566 | Sold Some | -107 | -2.91 % | $112,543 | $94,856 | $-17,687 | -15.71 % | $531 | | | | | | News Article | History of Ishares Trust-Ishares Russell 3000 Growth Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 3000 Index Fund | Specialty & Misc | 15,629 | Added More | 900 | 6.11 % | $493,251 | $415,731 | $-77,520 | -15.71 % | $-4,464 | | | | | | News Article | History of Ishares Trust-Ishares Russell 3000 Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds I-Loomis Sayles Bond Fund | Specialty & Misc | | Sold All | -21,222 | -100 % | | | | -15.71 % | $105,261 | | | | | | News Article | History of Loomis Sayles Funds I-Loomis Sayles Bond Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds Ii-Loomis Sayles Aggressive Growth Fund | Mid-Cap Growth | | Sold All | -33,592 | -100 % | | | | -15.71 % | $166,616 | | | | | | News Article | History of Loomis Sayles Funds Ii-Loomis Sayles Aggressive Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds Ii-Loomis Sayles Small Cap Growth Fund | Small-Cap Growth | 26,946 | Added More | 5,724 | 26.97 % | $850,416 | $716,764 | $-133,652 | -15.71 % | $-28,391 | | | | | | News Article | History of Loomis Sayles Funds Ii-Loomis Sayles Small Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds-Vanguard Strategic Equity Fund | Specialty & Misc | 38,116 | Sold Some | -214,384 | -84.90 % | $1,202,941 | $1,013,886 | $-189,055 | -15.71 % | $1,063,345 | | | | | | News Article | History of Vanguard Horizon Funds-Vanguard Strategic Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds-Vanguard Strategic Small-Cap Equity Fund | Small-Cap Core | | Sold All | -18,300 | -100 % | | | | -15.71 % | $90,768 | | | | | | News Article | History of Vanguard Horizon Funds-Vanguard Strategic Small-Cap Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Janus Aspen Series-Global Life Sciences Portfolio | Science & Tech | 7,641 | Added More | 464 | 6.46 % | $241,226 | $203,251 | $-37,976 | -15.74 % | $-2,306 | | | | | | News Article | History of Janus Aspen Series-Global Life Sciences Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Old Mutual Advisor Funds Ii-Old Mutual Strategic Small Company Fund | Small-Cap Core | | Sold All | -3,478 | -100 % | | | | -15.74 % | $17,286 | | | | | | News Article | History of Old Mutual Advisor Funds Ii-Old Mutual Strategic Small Company Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds-Equity Index Fund | Specialty & Misc | 38,442 | Added More | 24,632 | 178.36 % | $1,213,614 | $1,022,557 | $-191,057 | -15.74 % | $-122,421 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds-Equity Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds-Growth Equity Fund | Multi-Cap Growth | | Sold All | -19,871 | -100 % | | | | -15.74 % | $98,759 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds-Growth Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds-Vanguard Extended Market Index Fund | Mid-Cap Core | 346,089 | New Holding | 346,089 | 100 % | $10,926,030 | $9,205,967 | $-1,720,062 | -15.74 % | $-1,720,062 | | | | | | News Article | History of Vanguard Index Funds-Vanguard Extended Market Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds-Vanguard Growth Index Fund | Large-Cap Growth | 437,761 | New Holding | 437,761 | 100 % | $13,820,115 | $11,644,443 | $-2,175,672 | -15.74 % | $-2,175,672 | | | | | | News Article | History of Vanguard Index Funds-Vanguard Growth Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds-Vanguard Total Stock Market Index Fund | Multi-Cap Core | 527,061 | New Holding | 527,061 | 100 % | $16,639,316 | $14,019,823 | $-2,619,493 | -15.74 % | $-2,619,493 | | | | | | News Article | History of Vanguard Index Funds-Vanguard Total Stock Market Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds-Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 21,398 | Sold Some | -350 | -1.60 % | $675,535 | $569,187 | $-106,348 | -15.74 % | $1,740 | | | | | | News Article | History of Vanguard Balanced Index Funds-Vanguard Balanced Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds-Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 27,198 | Added More | 5,450 | 25.05 % | $858,641 | $723,467 | $-135,174 | -15.74 % | $-27,087 | | | | | | News Article | History of Vanguard Balanced Index Funds-Vanguard Balanced Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | N-Q | Touchstone Funds Group Trust-Touchstone Healthcare And Biotechnology Fund | Health/Biotech | | Sold All | -19,540 | -100 % | | | | -14.74 % | $89,884 | | | | | | News Article | History of Touchstone Funds Group Trust-Touchstone Healthcare And Biotechnology Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | N-Q | Turner Funds-Turner Small Cap Growth Fund | Small-Cap Growth | | Sold All | -42,230 | -100 % | | | | -14.74 % | $194,258 | | | | | | News Article | History of Turner Funds-Turner Small Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-Q | Nicholas Applegate Institutional Funds-International Growth Fund | Multi-Cap Growth | 2,300 | Sold Some | -1,400 | -37.83 % | $72,036 | $61,180 | $-10,856 | -15.07 % | $6,608 | | | | | | News Article | History of Nicholas Applegate Institutional Funds-International Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-Q | Mellon Institutional Funds Investment Trust-The Boston Company Small Cap Growth Fund | Small-Cap Growth | 44,480 | New Holding | 44,480 | 100 % | $1,376,656 | $1,183,168 | $-193,488 | -14.05 % | $-193,488 | | | | | | News Article | History of Mellon Institutional Funds Investment Trust-The Boston Company Small Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds-Oppenheimer Main Street Fundva | Specialty & Misc | 7,900 | New Holding | 7,900 | 100 % | $244,505 | $210,140 | $-34,365 | -14.05 % | $-34,365 | | | | | | News Article | History of Oppenheimer Variable Account Funds-Oppenheimer Main Street Fundva Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-21 | 2009-06-30 | N-CSR | Oppenheimer Main Street Small Cap Fund-Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 33,740 | New Holding | 33,740 | 100 % | $1,044,253 | $897,484 | $-146,769 | -14.05 % | $-146,769 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund-Oppenheimer Main Street Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-21 | 2009-06-30 | N-CSRS | Variable Insurance Products Fund Iv-Health Care Portfolio | Health/Biotech | | Sold All | -3,664 | -100 % | | | | -14.05 % | $15,938 | | | | | | News Article | History of Variable Insurance Products Fund Iv-Health Care Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-19 | 2009-06-30 | N-CSRS | Mutual Of America Institutional Funds Inc-Bond Fund | Specialty & Misc | 625 | Added More | 31 | 5.21 % | $19,013 | $16,625 | $-2,388 | -12.55 % | $-118 | | | | | | News Article | History of Mutual Of America Institutional Funds Inc-Bond Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-18 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 3,295,505 | Added More | 72,552 | 2.25 % | $97,843,543 | $87,660,433 | $-10,183,110 | -10.40 % | $-224,186 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-18 | 2009-06-30 | 13F-HR | Us Bancorp De | Institution | 1,005 | Added More | 5 | 0.50 % | $29,838 | $26,733 | $-3,105 | -10.40 % | $-15 | | | | | | News Article | History of Us Bancorp De Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Ashford Capital Management Inc | Institution | 493,100 | Added More | 203,800 | 70.44 % | $14,748,621 | $13,116,460 | $-1,632,161 | -11.06 % | $-674,578 | | | | | | News Article | History of Ashford Capital Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Baker Bros Advisors Llc | Institution | | Sold All | -36,578 | -100 % | | | | -11.06 % | $121,073 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Madison Square Investors Llc | No Data | 434 | No Change | 0 | 0 % | $12,981 | $11,544 | $-1,437 | -11.06 % | $0 | | | | | | News Article | History of Madison Square Investors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Morgan Stanley | Institution | 252,285 | Sold Some | -143,830 | -36.31 % | $7,545,844 | $6,710,781 | $-835,063 | -11.06 % | $476,077 | | | | | | News Article | History of Morgan Stanley Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-07-30 | 13F-HR | Sac Capital Advisors Lp | No Data | | Sold All | -55,221 | -100 % | | | | -14.02 % | $239,659 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Altrinsic Global Advisors Llc | Institution | 100,000 | No Change | 0 | 0 % | $3,094,000 | $2,660,000 | $-434,000 | -14.02 % | $0 | | | | | | News Article | History of Altrinsic Global Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | American International Group Inc | Institution | 46,058 | Added More | 873 | 1.93 % | $1,425,035 | $1,225,143 | $-199,892 | -14.02 % | $-3,789 | | | | | | News Article | History of American International Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Aqr Capital Management Llc | Institution | | Sold All | -13,200 | -100 % | | | | -14.02 % | $57,288 | | | | | | News Article | History of Aqr Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Axa | Institution | 1,524,473 | Added More | 332,548 | 27.90 % | $47,167,195 | $40,550,982 | $-6,616,213 | -14.02 % | $-1,443,258 | | | | | | News Article | History of Axa Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Bam Management Llc | No Data | 90,689 | Added More | 50,121 | 123.54 % | $2,805,918 | $2,412,327 | $-393,590 | -14.02 % | $-217,525 | | | | | | News Article | History of Bam Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 8,774 | Sold Some | -2,755 | -23.89 % | $271,468 | $233,388 | $-38,079 | -14.02 % | $11,957 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Bridger Management Llc | Institution | 723,206 | Added More | 323,206 | 80.80 % | $22,375,994 | $19,237,280 | $-3,138,714 | -14.02 % | $-1,402,714 | | | | | | News Article | History of Bridger Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Bridgeway Capital Management Inc | Institution | 24,400 | No Change | 0 | 0 % | $754,936 | $649,040 | $-105,896 | -14.02 % | $0 | | | | | | News Article | History of Bridgeway Capital Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Capital World Investor | Institution | 1,000,000 | No Change | 0 | 0 % | $30,940,000 | $26,600,000 | $-4,340,000 | -14.02 % | $0 | | | | | | News Article | History of Capital World Investor Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Caxton Associates Llc | Institution | | Sold All | -44,033 | -100 % | | | | -14.02 % | $191,103 | | | | | | News Article | History of Caxton Associates Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Citadel L P | Institution | 41,250 | Sold Some | -98,441 | -70.47 % | $1,276,275 | $1,097,250 | $-179,025 | -14.02 % | $427,234 | | | | | | News Article | History of Citadel L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Citigroup Inc | Institution | 178,855 | Added More | 103,297 | 136.71 % | $5,533,774 | $4,757,543 | $-776,231 | -14.02 % | $-448,309 | | | | | | News Article | History of Citigroup Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Clearbridge Advisors Llc | Institution | 496,106 | Added More | 267,523 | 117.03 % | $15,349,520 | $13,196,420 | $-2,153,100 | -14.02 % | $-1,161,050 | | | | | | News Article | History of Clearbridge Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Credit Agricole S A | Institution | 8,627 | Added More | 4,667 | 117.85 % | $266,919 | $229,478 | $-37,441 | -14.02 % | $-20,255 | | | | | | News Article | History of Credit Agricole S A Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Deerfield Management Co | Institution | 780,314 | Added More | 345,880 | 79.61 % | $24,142,915 | $20,756,352 | $-3,386,563 | -14.02 % | $-1,501,119 | | | | | | News Article | History of Deerfield Management Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Dekabank Deutsche Girozentrale | No Data | 90,500 | New Holding | 90,500 | 100 % | $2,800,070 | $2,407,300 | $-392,770 | -14.02 % | $-392,770 | | | | | | News Article | History of Dekabank Deutsche Girozentrale Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Delaware Management Business Trust | Institution | 124,465 | Added More | 20,205 | 19.37 % | $3,850,947 | $3,310,769 | $-540,178 | -14.02 % | $-87,690 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Driehaus Capital Management Llc | Institution | | Sold All | -42,095 | -100 % | | | | -14.02 % | $182,692 | | | | | | News Article | History of Driehaus Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Employees Retirement System Of Texa | Institution | | Sold All | -13,400 | -100 % | | | | -14.02 % | $58,156 | | | | | | News Article | History of Employees Retirement System Of Texa Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Epoch Investment Partners Inc | Institution | 46,900 | New Holding | 46,900 | 100 % | $1,451,086 | $1,247,540 | $-203,546 | -14.02 % | $-203,546 | | | | | | News Article | History of Epoch Investment Partners Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Fifth Third Bancorp | Institution | 500 | No Change | 0 | 0 % | $15,470 | $13,300 | $-2,170 | -14.02 % | $0 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Fmr Corp | Institution | 1,512,900 | Added More | 99,602 | 7.04 % | $46,809,126 | $40,243,140 | $-6,565,986 | -14.02 % | $-432,273 | | | | | | News Article | History of Fmr Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Geode Capital Management Llc | Institution | 118,255 | Added More | 1,950 | 1.67 % | $3,658,810 | $3,145,583 | $-513,227 | -14.02 % | $-8,463 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 309,127 | Sold Some | -125,712 | -28.91 % | $9,564,389 | $8,222,778 | $-1,341,611 | -14.02 % | $545,590 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Haw D E And Co Inc | Institution | 3,561,056 | Added More | 74,064 | 2.12 % | $110,179,073 | $94,724,090 | $-15,454,983 | -14.02 % | $-321,438 | | | | | | News Article | History of Haw D E And Co Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Hbk Investments L P | Institution | | Sold All | -17,000 | -100 % | | | | -14.02 % | $73,780 | | | | | | News Article | History of Hbk Investments L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Highside Capital Management L P | Institution | 500,000 | No Change | 0 | 0 % | $15,470,000 | $13,300,000 | $-2,170,000 | -14.02 % | $0 | | | | | | News Article | History of Highside Capital Management L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Ing Groep Nv | Institution | 348,437 | New Holding | 348,437 | 100 % | $10,780,641 | $9,268,424 | $-1,512,217 | -14.02 % | $-1,512,217 | | | | | | News Article | History of Ing Groep Nv Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Jacobs Levy Equity Management Inc | Institution | 12,200 | No Change | 0 | 0 % | $377,468 | $324,520 | $-52,948 | -14.02 % | $0 | | | | | | News Article | History of Jacobs Levy Equity Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Jane Street Holding Llc | Institution | 32,099 | New Holding | 32,099 | 100 % | $993,143 | $853,833 | $-139,310 | -14.02 % | $-139,310 | | | | | | News Article | History of Jane Street Holding Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Janus Capital Management Llc | Institution | 707,143 | Added More | 68,616 | 10.74 % | $21,879,004 | $18,810,004 | $-3,069,001 | -14.02 % | $-297,793 | | | | | | News Article | History of Janus Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Jefferies Group Inc | Institution | | Sold All | -7,500 | -100 % | | | | -14.02 % | $32,550 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Jesaga Advisers Llc | Institution | | Sold All | -25,000 | -100 % | | | | -14.02 % | $108,500 | | | | | | News Article | History of Jesaga Advisers Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Kbc Group Nv | Institution | | Sold All | -161 | -100 % | | | | -14.02 % | $699 | | | | | | News Article | History of Kbc Group Nv Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Loomis Sayles And Co L P | Institution | 82,046 | Sold Some | -50,701 | -38.19 % | $2,538,503 | $2,182,424 | $-356,080 | -14.02 % | $220,042 | | | | | | News Article | History of Loomis Sayles And Co L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Lord Abbett And Co Llc | Institution | 2,641,910 | Sold Some | -1,592,471 | -37.60 % | $81,740,695 | $70,274,806 | $-11,465,889 | -14.02 % | $6,911,324 | | | | | | News Article | History of Lord Abbett And Co Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Managed Account Advisors Llc | Institution | 3,844 | New Holding | 3,844 | 100 % | $118,933 | $102,250 | $-16,683 | -14.02 % | $-16,683 | | | | | | News Article | History of Managed Account Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Martingale Asset Management L P | Institution | 54,800 | Added More | 17,500 | 46.91 % | $1,695,512 | $1,457,680 | $-237,832 | -14.02 % | $-75,950 | | | | | | News Article | History of Martingale Asset Management L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 15,307 | New Holding | 15,307 | 100 % | $473,599 | $407,166 | $-66,432 | -14.02 % | $-66,432 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Millennium Management Llc | Institution | | Sold All | -82,186 | -100 % | | | | -14.02 % | $356,687 | | | | | | News Article | History of Millennium Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | New York State Common Retirement Fund | Institution | 17,770 | Added More | 14,170 | 393.61 % | $549,804 | $472,682 | $-77,122 | -14.02 % | $-61,498 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Nomura Asset Management Co Ltd | Institution | 564,600 | Added More | 415,100 | 277.65 % | $17,468,724 | $15,018,360 | $-2,450,364 | -14.02 % | $-1,801,534 | | | | | | News Article | History of Nomura Asset Management Co Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Northern Trust Co Of Connecticut | Institution | 19,540 | Sold Some | -24,591 | -55.72 % | $604,568 | $519,764 | $-84,804 | -14.02 % | $106,725 | | | | | | News Article | History of Northern Trust Co Of Connecticut Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Northern Trust Corp | Institution | 626,252 | Added More | 120,369 | 23.79 % | $19,376,237 | $16,658,303 | $-2,717,934 | -14.02 % | $-522,401 | | | | | | News Article | History of Northern Trust Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Onar Capital Management Llc | Institution | 36,000 | New Holding | 36,000 | 100 % | $1,113,840 | $957,600 | $-156,240 | -14.02 % | $-156,240 | | | | | | News Article | History of Onar Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Oppenheimer Funds Inc | Institution | 57,580 | Added More | 50,180 | 678.10 % | $1,781,525 | $1,531,628 | $-249,897 | -14.02 % | $-217,781 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Orbimed Advisors Llc | Institution | 2,256,100 | Sold Some | -26,300 | -1.15 % | $69,803,734 | $60,012,260 | $-9,791,474 | -14.02 % | $114,142 | | | | | | News Article | History of Orbimed Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Palo Alto Investors Llc | Institution | 2,614,320 | Added More | 4,500 | 0.17 % | $80,887,061 | $69,540,912 | $-11,346,149 | -14.02 % | $-19,530 | | | | | | News Article | History of Palo Alto Investors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Partner Fund Management Lp | Institution | 104,118 | New Holding | 104,118 | 100 % | $3,221,411 | $2,769,539 | $-451,872 | -14.02 % | $-451,872 | | | | | | News Article | History of Partner Fund Management Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Partner Investment Management Lp | Institution | 63,942 | New Holding | 63,942 | 100 % | $1,978,365 | $1,700,857 | $-277,508 | -14.02 % | $-277,508 | | | | | | News Article | History of Partner Investment Management Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Passport Management Llc | Institution | 265,500 | New Holding | 265,500 | 100 % | $8,214,570 | $7,062,300 | $-1,152,270 | -14.02 % | $-1,152,270 | | | | | | News Article | History of Passport Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Pequot Capital Management Inc | Institution | | Sold All | -1,122,386 | -100 % | | | | -14.02 % | $4,871,155 | | | | | | News Article | History of Pequot Capital Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Perceptive Advisors Llc | Institution | 200,000 | New Holding | 200,000 | 100 % | $6,188,000 | $5,320,000 | $-868,000 | -14.02 % | $-868,000 | | | | | | News Article | History of Perceptive Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 2,185,988 | Added More | 1,425,400 | 187.40 % | $67,634,469 | $58,147,281 | $-9,487,188 | -14.02 % | $-6,186,236 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Principal Financial Group Inc | Institution | 191,410 | Added More | 106,910 | 126.52 % | $5,922,225 | $5,091,506 | $-830,719 | -14.02 % | $-463,989 | | | | | | News Article | History of Principal Financial Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Principled Asset Administration Llc | Institution | 663,800 | New Holding | 663,800 | 100 % | $20,537,972 | $17,657,080 | $-2,880,892 | -14.02 % | $-2,880,892 | | | | | | News Article | History of Principled Asset Administration Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Provident Investment Counsel | Institution | | Sold All | -221,229 | -100 % | | | | -14.02 % | $960,134 | | | | | | News Article | History of Provident Investment Counsel Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | | Sold All | -7,571 | -100 % | | | | -14.02 % | $32,858 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 650 | Sold Some | -27,030 | -97.65 % | $20,111 | $17,290 | $-2,821 | -14.02 % | $117,310 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Russell Frank Co | Institution | 2,300 | Sold Some | -12,502 | -84.46 % | $71,162 | $61,180 | $-9,982 | -14.02 % | $54,259 | | | | | | News Article | History of Russell Frank Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Td Asset Management Inc | Institution | 30,000 | Added More | 3,610 | 13.67 % | $928,200 | $798,000 | $-130,200 | -14.02 % | $-15,667 | | | | | | News Article | History of Td Asset Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Thales Fund Management Llc | Institution | | Sold All | -14,921 | -100 % | | | | -14.02 % | $64,757 | | | | | | News Article | History of Thales Fund Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Tokum Capital Management Lp | Institution | 77,277 | Added More | 26,300 | 51.59 % | $2,390,950 | $2,055,568 | $-335,382 | -14.02 % | $-114,142 | | | | | | News Article | History of Tokum Capital Management Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Traus Capital Management Llc | Institution | 146,895 | Added More | 25,000 | 20.50 % | $4,544,931 | $3,907,407 | $-637,524 | -14.02 % | $-108,500 | | | | | | News Article | History of Traus Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Trellus Management Company Llc | Institution | 100,000 | Added More | 80,000 | 400.00 % | $3,094,000 | $2,660,000 | $-434,000 | -14.02 % | $-347,200 | | | | | | News Article | History of Trellus Management Company Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Two Sigma Investments Llc | Institution | | Sold All | -33,286 | -100 % | | | | -14.02 % | $144,461 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Value Line Inc | Institution | | Sold All | -61,000 | -100 % | | | | -14.02 % | $264,740 | | | | | | News Article | History of Value Line Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Vanguard Group Inc | Institution | 2,272,653 | Sold Some | -218,474 | -8.77 % | $70,315,884 | $60,452,570 | $-9,863,314 | -14.02 % | $948,177 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Walleye Trading Llc | Institution | 580 | New Holding | 580 | 100 % | $17,945 | $15,428 | $-2,517 | -14.02 % | $-2,517 | | | | | | News Article | History of Walleye Trading Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Weintraub Capital Management Lp | Institution | 100,000 | New Holding | 100,000 | 100 % | $3,094,000 | $2,660,000 | $-434,000 | -14.02 % | $-434,000 | | | | | | News Article | History of Weintraub Capital Management Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Weiss Multi-Strategy Advisers Llc | Institution | 28,700 | New Holding | 28,700 | 100 % | $887,978 | $763,420 | $-124,558 | -14.02 % | $-124,558 | | | | | | News Article | History of Weiss Multi-Strategy Advisers Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Wellington Management Co Llp | Institution | 3,843,985 | Sold Some | -129,360 | -3.25 % | $118,932,896 | $102,250,001 | $-16,682,895 | -14.02 % | $561,422 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Zebra Capital Management Llc | Institution | | Sold All | -100 | -100 % | | | | -14.02 % | $434 | | | | | | News Article | History of Zebra Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-14 | 2009-03-31 | 13F-HR/A | Orbimed Advisors Llc | Institution | 2,282,400 | Sold Some | -500,400 | -17.98 % | $70,617,456 | $60,711,840 | $-9,905,616 | -14.02 % | $2,171,736 | | | | | | News Article | History of Orbimed Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Allstate Insurance Co | Institution | | Sold All | -17,900 | -100 % | | | | -13.80 % | $76,254 | | | | | | News Article | History of Allstate Insurance Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Ameriprise Financial Inc | Institution | 130,536 | Sold Some | -34,836 | -21.06 % | $4,028,341 | $3,472,258 | $-556,083 | -13.80 % | $148,401 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 587,707 | Sold Some | -235,316 | -28.59 % | $18,136,638 | $15,633,006 | $-2,503,632 | -13.80 % | $1,002,446 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Barclays Plc | Institution | 38,370 | Sold Some | -90,641 | -70.25 % | $1,184,098 | $1,020,642 | $-163,456 | -13.80 % | $386,131 | | | | | | News Article | History of Barclays Plc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Capital Fund Management S A | Institution | 484 | Sold Some | -1,446 | -74.92 % | $14,936 | $12,874 | $-2,062 | -13.80 % | $6,160 | | | | | | News Article | History of Capital Fund Management S A Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 13,400 | New Holding | 13,400 | 100 % | $413,524 | $356,440 | $-57,084 | -13.80 % | $-57,084 | | | | | | News Article | History of Eaton Vance Management Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Expo Capital Management Llc | Institution | 175,000 | New Holding | 175,000 | 100 % | $5,400,500 | $4,655,000 | $-745,500 | -13.80 % | $-745,500 | | | | | | News Article | History of Expo Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Federated Investors Inc | Institution | | Sold All | -61,200 | -100 % | | | | -13.80 % | $260,712 | | | | | | News Article | History of Federated Investors Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | First Trust Advisors Lp | Institution | | Sold All | -20,795 | -100 % | | | | -13.80 % | $88,587 | | | | | | News Article | History of First Trust Advisors Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Fortis Investments Management Usa Inc | Institution | | Sold All | -85,333 | -100 % | | | | -13.80 % | $363,519 | | | | | | News Article | History of Fortis Investments Management Usa Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Highbridge Capital Management Llc | Institution | | Sold All | -153,598 | -100 % | | | | -13.80 % | $654,327 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Ing Investment Management Co | Institution | 375,637 | Added More | 61,800 | 19.69 % | $11,592,158 | $9,991,944 | $-1,600,214 | -13.80 % | $-263,268 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR/A | Ironbridge Capital Management Llc | Institution | 420,558 | Added More | 27,646 | 7.03 % | $12,978,420 | $11,186,843 | $-1,791,577 | -13.80 % | $-117,772 | | | | | | News Article | History of Ironbridge Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | J P Morgan Chase And Co | Institution | 176,770 | Added More | 109,594 | 163.14 % | $5,455,122 | $4,702,082 | $-753,040 | -13.80 % | $-466,870 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Knight Capital Group Inc | Institution | 16,748 | Sold Some | -1,837 | -9.88 % | $516,843 | $445,497 | $-71,346 | -13.80 % | $7,826 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Marshall Ilsley Corp | Institution | 56,038 | Added More | 3,040 | 5.73 % | $1,729,333 | $1,490,611 | $-238,722 | -13.80 % | $-12,950 | | | | | | News Article | History of Marshall Ilsley Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Oracle Investment Management Inc | Institution | 550,000 | Sold Some | -21,057 | -3.68 % | $16,973,000 | $14,630,000 | $-2,343,000 | -13.80 % | $89,703 | | | | | | News Article | History of Oracle Investment Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Renaissance Technologies Corp | Institution | 86,833 | Sold Some | -94,200 | -52.03 % | $2,679,666 | $2,309,758 | $-369,909 | -13.80 % | $401,292 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Ubs Ag | Institution | 215,018 | Sold Some | -122,733 | -36.33 % | $6,635,455 | $5,719,479 | $-915,977 | -13.80 % | $522,843 | | | | | | News Article | History of Ubs Ag Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Veritable L P | Institution | 7,600 | New Holding | 7,600 | 100 % | $234,536 | $202,160 | $-32,376 | -13.80 % | $-32,376 | | | | | | News Article | History of Veritable L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Wells Fargo And Co | Institution | 227,264 | Sold Some | -21,371 | -8.59 % | $7,013,367 | $6,045,222 | $-968,145 | -13.80 % | $91,040 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Wexford Capital Llc | Institution | | Sold All | -10,200 | -100 % | | | | -13.80 % | $43,452 | | | | | | News Article | History of Wexford Capital Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Zacks Investment Management | Institution | | Sold All | -17,297 | -100 % | | | | -13.80 % | $73,685 | | | | | | News Article | History of Zacks Investment Management Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | 128,587 | Added More | 35,333 | 37.88 % | $4,022,201 | $3,420,414 | $-601,787 | -14.96 % | $-165,358 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Cadence Capital Management Llc | Institution | 487,690 | Added More | 122,100 | 33.39 % | $15,254,943 | $12,972,554 | $-2,282,389 | -14.96 % | $-571,428 | | | | | | News Article | History of Cadence Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Credit Suisse First Boston | Institution | 66,477 | Added More | 38,022 | 133.62 % | $2,079,401 | $1,768,288 | $-311,112 | -14.96 % | $-177,943 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Dafna Capital Management Llc | Institution | 151,700 | Added More | 133,200 | 720.00 % | $4,745,176 | $4,035,220 | $-709,956 | -14.96 % | $-623,376 | | | | | | News Article | History of Dafna Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | 500,000 | Added More | 275,000 | 122.22 % | $15,640,000 | $13,300,000 | $-2,340,000 | -14.96 % | $-1,287,000 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | First Mercantile Trust Co | Institution | 3,090 | Sold Some | -66,858 | -95.58 % | $96,655 | $82,194 | $-14,461 | -14.96 % | $312,895 | | | | | | News Article | History of First Mercantile Trust Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Fortaleza Asset Management Inc | Institution | 21,425 | Added More | 350 | 1.66 % | $670,174 | $569,905 | $-100,269 | -14.96 % | $-1,638 | | | | | | News Article | History of Fortaleza Asset Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Franklin Resources Inc | Institution | 480,445 | Added More | 249,735 | 108.24 % | $15,028,320 | $12,779,837 | $-2,248,483 | -14.96 % | $-1,168,760 | | | | | | News Article | History of Franklin Resources Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Ig Investment Management Ltd | Institution | 1,450 | Added More | 300 | 26.08 % | $45,356 | $38,570 | $-6,786 | -14.96 % | $-1,404 | | | | | | News Article | History of Ig Investment Management Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Knott David M | Institution | 593,768 | No Change | 0 | 0 % | $18,573,063 | $15,794,229 | $-2,778,834 | -14.96 % | $0 | | | | | | News Article | History of Knott David M Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Lee Munder Investments Ltd | Institution | 62,127 | Added More | 29,000 | 87.54 % | $1,943,333 | $1,652,578 | $-290,754 | -14.96 % | $-135,720 | | | | | | News Article | History of Lee Munder Investments Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Rbc Asset Management Inc | Institution | 16,200 | Sold Some | -106,700 | -86.81 % | $506,736 | $430,920 | $-75,816 | -14.96 % | $499,356 | | | | | | News Article | History of Rbc Asset Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Usquehanna International Group Llp | Institution | 72,540 | Added More | 45,127 | 164.61 % | $2,269,051 | $1,929,564 | $-339,487 | -14.96 % | $-211,194 | | | | | | News Article | History of Usquehanna International Group Llp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Virginia Retirement Systems Et Al | Institution | 12,600 | Sold Some | -1,700 | -11.88 % | $394,128 | $335,160 | $-58,968 | -14.96 % | $7,956 | | | | | | News Article | History of Virginia Retirement Systems Et Al Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | World Asset Management Inc | Institution | 7,216 | No Change | 0 | 0 % | $225,716 | $191,946 | $-33,771 | -14.96 % | $0 | | | | | | News Article | History of World Asset Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | American Century Companies Inc | Institution | 84,594 | Added More | 905 | 1.08 % | $2,651,176 | $2,250,200 | $-400,976 | -15.12 % | $-4,290 | | | | | | News Article | History of American Century Companies Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Amvescap Plc | Institution | 3,385 | Sold Some | -242,463 | -98.62 % | $106,086 | $90,041 | $-16,045 | -15.12 % | $1,149,275 | | | | | | News Article | History of Amvescap Plc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Bbt Capital Management Inc | Institution | | Sold All | -60,000 | -100 % | | | | -15.12 % | $284,400 | | | | | | News Article | History of Bbt Capital Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Blackrock Inc | No Data | 18,474 | New Holding | 18,474 | 100 % | $578,975 | $491,408 | $-87,567 | -15.12 % | $-87,567 | | | | | | News Article | History of Blackrock Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Charles Schwab Trust Company A Division Of Charles Schwab B | No Data | | Sold All | -18,380 | -100 % | | | | -15.12 % | $87,121 | | | | | | News Article | History of Charles Schwab Trust Company A Division Of Charles Schwab B Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Ectoral Asset Management Inc | Institution | 4,396,346 | Added More | 1,082,300 | 32.65 % | $137,781,484 | $116,942,804 | $-20,838,680 | -15.12 % | $-5,130,102 | | | | | | News Article | History of Ectoral Asset Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Glenmede Trust Co Na | Institution | 7,258 | Sold Some | -920 | -11.24 % | $227,466 | $193,063 | $-34,403 | -15.12 % | $4,361 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 26,229 | Sold Some | -6,014 | -18.65 % | $822,017 | $697,691 | $-124,325 | -15.12 % | $28,506 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Padco Advisors Inc | Institution | 107,231 | Added More | 13,184 | 14.01 % | $3,360,620 | $2,852,345 | $-508,275 | -15.12 % | $-62,492 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Palisade Capital Management Llc | Institution | | Sold All | -155,046 | -100 % | | | | -15.12 % | $734,918 | | | | | | News Article | History of Palisade Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Trilogy Global Advisors Llc | Institution | 18,700 | No Change | 0 | 0 % | $586,058 | $497,420 | $-88,638 | -15.12 % | $0 | | | | | | News Article | History of Trilogy Global Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 423,600 | Sold Some | -45,500 | -9.69 % | $13,275,624 | $11,267,760 | $-2,007,864 | -15.12 % | $215,670 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Bank Of Hawaii | Institution | 15,500 | Sold Some | -1,700 | -9.88 % | $486,080 | $412,300 | $-73,780 | -15.17 % | $8,092 | | | | | | News Article | History of Bank Of Hawaii Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 83,165 | Added More | 8,700 | 11.68 % | $2,608,054 | $2,212,189 | $-395,865 | -15.17 % | $-41,412 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | G Americas Securities Llc | Institution | 17,749 | Added More | 3,248 | 22.39 % | $556,609 | $472,123 | $-84,485 | -15.17 % | $-15,460 | | | | | | News Article | History of G Americas Securities Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Hartford Investment Management Co | Institution | 118,942 | Added More | 43,950 | 58.60 % | $3,730,021 | $3,163,857 | $-566,164 | -15.17 % | $-209,202 | | | | | | News Article | History of Hartford Investment Management Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 51,096 | Sold Some | -7,699 | -13.09 % | $1,602,371 | $1,359,154 | $-243,217 | -15.17 % | $36,647 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Oshaughnessy Asset Management Llc | Institution | 1,465 | New Holding | 1,465 | 100 % | $45,942 | $38,969 | $-6,973 | -15.17 % | $-6,973 | | | | | | News Article | History of Oshaughnessy Asset Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Overeign Asset Management Corp | Institution | 95,686 | Sold Some | -2,675 | -2.71 % | $3,000,713 | $2,545,248 | $-455,465 | -15.17 % | $12,733 | | | | | | News Article | History of Overeign Asset Management Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Uffolk Capital Management Llc | Institution | | Sold All | -10,000 | -100 % | | | | -15.17 % | $47,600 | | | | | | News Article | History of Uffolk Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-10 | 2009-05-31 | N-CSR | Tdax Funds Inc-Tdax Independence 2010 Exchange-Traded Fund | Mixed-Asset Target 2010 Funds | 85 | New Holding | 85 | 100 % | $2,666 | $2,261 | $-405 | -15.17 % | $-405 | | | | | | News Article | History of Tdax Funds Inc-Tdax Independence 2010 Exchange-Traded Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-10 | 2009-05-31 | N-CSR | Tdax Funds Inc-Tdax Independence 2020 Exchange-Traded Fund | Mixed-Asset Target 2020 Funds | 553 | New Holding | 553 | 100 % | $17,342 | $14,710 | $-2,632 | -15.17 % | $-2,632 | | | | | | News Article | History of Tdax Funds Inc-Tdax Independence 2020 Exchange-Traded Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-10 | 2009-05-31 | N-CSR | Tdax Funds Inc-Tdax Independence 2030 Exchange-Traded Fund | Mixed-Asset Target 2030 Funds | 648 | New Holding | 648 | 100 % | $20,321 | $17,237 | $-3,084 | -15.17 % | $-3,084 | | | | | | News Article | History of Tdax Funds Inc-Tdax Independence 2030 Exchange-Traded Fund Ownership Of Onyx |
RSS feed for ONXX